dr mike glp 1 The #1 Mistake People Make on GLP-1s Novo CEO outlines long-term strategy

A paper published October 2025 assessed whether non-diabetic overweight or obese patients who took GLP-1 agonists were more likely to develop AMD from no disease at baseline, compared to patients who took other weight loss drugs

Activation of glucagon-like peptide-1 receptor in microglia attenuates neuroinflammation-induced glial scarring via rescuing Arf and Rho GAP adapter protein 3 expressions after nerve injury

A.Fernndez-RealJ

Frequently Asked Questions About Semaglutide vs Tirzepatide What is the main difference between Semaglutide and Tirzepatide

p=0.16), and rehospitalization for HF or death (HR 1.36

For those of you who arent needle shy, the once-a-week option is probably the better fit, but you do have to learn how to inject yourself and make sure you dont miss a shot